Andrew Saik Vyne Therapeutics Inc. (VYNE) insider trading activity
Andrew Saik is Chief Financial Officer of VYNE Therapeutics Inc.. Currently has a direct ownership of 116,468 shares of VYNE, which is worth approximately $315,628. The most recent transaction as insider was on May 28, 2021, when has been sold 3,017 shares (Common Stock) at a price of $3.36 per share, resulting in proceeds of $10,137. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
116K
0%
3M change
0%
12M change
Total Value Held
$315,628
Andrew Saik Transaction History
Also insider at
AS
Andrew Saik
Chief Financial Officer
Morristown, NJ